Abstract # 2157 Preliminary Toxicity and Quality of Life (QoL) Data From a Randomized Phase III Trial Investigating the Optimal Method of Sequencing Radiation (XRT) and Short Course Total Androgen Blockade (TAB) in Prostate Cancer (PC)

Presenter: Malone, Shawn

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos

About the Presenter:
Dr. Malone has worked at the Ottawa Hospital Regional Cancer Centre for the last 11 years. He is an Associate Professor at the University of Ottawa. He graduated from Princess Margaret Hospital in 1994. Dr. Malone did further training at the Joint Centre in Boston for Stereotactic Radiotherapy and conformal radiotherapy. He heads the Brain Tumour Site Group in Ottawa and runs the Stereotactic Radiosurgery and Conformal Prostate Radiotherapy Program. Dr. Malone has 50 abstracts and publications as 1st author or coauthor. Special interests include precision radiation for brain tumours and prostate cancer.
Contact the presenter at: SMalone@Ottawahospital.on.ca

Malone, Shawn (1) ; Eapen, L (1) ; E, C (1) ; MacRae, R (1) ; Samant, R (1) ; Kendall, W (1) ; Bowen, S (1) ; Grimes, S

(1) ; Robertson, S (1) ; Addison, C (1) ; Gallant, V (1) .

1. Ottawa Hospital Regional Cancer Centre, Ottawa, ON, Canada.

E-mail a friend about this abstract:
Enter email address:   

Abstracts main page